Open AccessDiagnostic Value of <sup>18</sup>F-FDG PET/CT in Patients with Carcinoma of Unknown Primary
Author(s) -
Arzu Cengiz,
Sibel Göksel,
Yakup Yürekli
Publication year - 2018
Publication title -
molecular imaging and radionuclide therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.292
H-Index - 7
eISSN - 2147-1959
pISSN - 2146-1414
DOI - 10.4274/mirt.64426
Subject(s) - medicine , positron emission tomography , primary tumor , nuclear medicine , biopsy , prostate cancer , radiology , lung cancer , cancer , carcinoma , prostate , pathology , metastasis
The aim of this study is to investigate the clinical role of 18 F-fluorodeoxyglucose ( 18 F-FDG) positron emission tomography/computed tomography (PET/CT) in patients with carcinoma of unknown primary (CUP).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom